Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Ceapro Announces Technical Successes on Supercritical Fluid Drying Technology

Published: Tuesday, May 22, 2012
Last Updated: Tuesday, May 22, 2012
Bookmark and Share
Podium presentation at the 10th annual International Symposium of Supercritical Fluids in San Francisco.

Dr. Bernhard Seifried from Ceapro presented the latest results obtained from one of Ceapro's research programs using a supercritical drying technology. The presentation entitled "Supercritical Fluid Drying of High Molecular Weight Biopolymers for Particle Formulation and Delivery of Bioactives" was held under the Pharmaceutical Applications stream of the International Symposium on supercritical fluids currently ongoing in San Francisco at the Hyatt Regency hotel.

The goal from using this technology is to produce dry powder formulations of certain Ceapro products currently sold as liquid formulations. From a technological perspective, the process conditions facilitate the production of preservative free, sterile products, powders, fibres, and agglomerates. The wide range of very fine structures this technology produces facilitates easy solubilisation which is essential for many drying technologies to be successful.

"While we have initially presented this technology as a powdered beta glucan project, we realize that this technology might offer much more by becoming a platform suitable for many water-soluble products.", stated Gilles Gagnon, CEO of Ceapro. "With its potential usage for impregnation, coating and encapsulation of Ceapro's bio-actives, it is expected that this technology would enable Ceapro to offer product formulations which would be suitable for the transition to the functional food, nutraceutical and potentially pharmaceutical areas", added Mr. Gagnon.

Thus far the technology has been scaled up to pilot scale at the BioFoodTech Centre in Charlottetown Prince Edward Island. Each scale up process requires lead time to custom manufacture equipment that has been designed by Ceapro scientists. "Each step of our scale up has gone exceptionally well and this project has been a technical success to this point", said Dr. Bernhard Seifried, research scientist at Ceapro. To date the beta glucan purity has exceeded 90% and by adjusting the process conditions we have produced dried beta glucan in the form of microfibrils, sponge type material, and free flowing powder, which all show excellent solubilisation properties", added Dr Seifried. The next scale up runs are scheduled for the next quarter when Ceapro intends to produce multiple kilogram quantities of dried powder for evaluation by a food company. Product samples have also been sent to a specialty pharmaceutical company for testing.

"We congratulate Dr Seifried on his success to date on this totally novel technology. The beta glucan products produced thus far are beyond our expectations. Furthermore, applications of this technology might extend beyond Ceapro's current products making this technology potentially attractive as an out-license candidate to third parties requiring challenging drying solutions. We look forward to continuing an aggressive path toward commercialization", added Mr. Gagnon.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!